These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 24396024)

  • 1. Parallel-group 8-week study on chlorthalidone effects in hypertensives with low kidney function.
    Cirillo M; Marcarelli F; Mele AA; Romano M; Lombardi C; Bilancio G
    Hypertension; 2014 Apr; 63(4):692-7. PubMed ID: 24396024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bisoprolol vs. chlorthalidone: a randomized, double-blind, comparative study in arterial hypertension.
    Bueno J; Amiguet JA; Carasusan J; Cebollada J; Carretero J
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S189-92. PubMed ID: 11527126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Rahman M; Pressel S; Davis BR; Nwachuku C; Wright JT; Whelton PK; Barzilay J; Batuman V; Eckfeldt JH; Farber M; Henriquez M; Kopyt N; Louis GT; Saklayen M; Stanford C; Walworth C; Ward H; Wiegmann T
    Arch Intern Med; 2005 Apr; 165(8):936-46. PubMed ID: 15851647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chlorthalidone Versus Amlodipine for Hypertension in Kidney Transplant Recipients Treated With Tacrolimus: A Randomized Crossover Trial.
    Moes AD; Hesselink DA; van den Meiracker AH; Zietse R; Hoorn EJ
    Am J Kidney Dis; 2017 Jun; 69(6):796-804. PubMed ID: 28259499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antihypertensive efficacy of hydrochlorothiazide vs chlorthalidone combined with azilsartan medoxomil.
    Bakris GL; Sica D; White WB; Cushman WC; Weber MA; Handley A; Song E; Kupfer S
    Am J Med; 2012 Dec; 125(12):1229.e1-1229.e10. PubMed ID: 22939358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of long-term, low-dose, diuretic-based, antihypertensive therapy on glucose, lipid, uric acid, and potassium levels in older men and women with isolated systolic hypertension: The Systolic Hypertension in the Elderly Program. SHEP Cooperative Research Group.
    Savage PJ; Pressel SL; Curb JD; Schron EB; Applegate WB; Black HR; Cohen J; Davis BR; Frost P; Smith W; Gonzalez N; Guthrie GP; Oberman A; Rutan G; Probstfield JL; Stamler J
    Arch Intern Med; 1998 Apr; 158(7):741-51. PubMed ID: 9554680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changing the timing of antihypertensive therapy to reduce nocturnal blood pressure in CKD: an 8-week uncontrolled trial.
    Minutolo R; Gabbai FB; Borrelli S; Scigliano R; Trucillo P; Baldanza D; Laurino S; Mascia S; Conte G; De Nicola L
    Am J Kidney Dis; 2007 Dec; 50(6):908-17. PubMed ID: 18037091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the efficacy and safety of a hydrochlorothiazide to chlorthalidone medication change in veterans with hypertension.
    Matthews KA; Brenner MJ; Brenner AC
    Clin Ther; 2013 Sep; 35(9):1423-30. PubMed ID: 23993697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiproteinuric and blood pressure-lowering effects of a fixed-dose combination of losartan and hydrochlorothiazide in hypertensive patients with stage 3 chronic kidney disease.
    Abe M; Okada K; Maruyama T; Matsumoto K
    Pharmacotherapy; 2009 Sep; 29(9):1061-72. PubMed ID: 19698011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of resistant hypertension: aldosterone antagonists or intensification of diuretic therapy?
    Verdalles U; García de Vinuesa S; Goicoechea M; Macías N; Santos A; Perez de Jose A; Verde E; Yuste C; Luño J
    Nephrology (Carlton); 2015 Aug; 20(8):567-71. PubMed ID: 25818266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chlorthalidone for Hypertension in Advanced Chronic Kidney Disease.
    Agarwal R; Sinha AD; Cramer AE; Balmes-Fenwick M; Dickinson JH; Ouyang F; Tu W
    N Engl J Med; 2021 Dec; 385(27):2507-2519. PubMed ID: 34739197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of allopurinol on slowing allograft functional decline in kidney transplant recipients.
    Osadchuk L; Bashir MH; Tangirala B; Marcus RJ; Nashar K; Hussain SM; Sureshkumar KK
    Exp Clin Transplant; 2014 Jun; 12(3):190-4. PubMed ID: 24907717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal responses to long-term carotid baroreflex activation therapy in patients with drug-resistant hypertension.
    Alnima T; de Leeuw PW; Tan FE; Kroon AA;
    Hypertension; 2013 Jun; 61(6):1334-9. PubMed ID: 23589562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the antihypertensive effects of betaxolol and chlorthalidone as monotherapy and in combination.
    Burris JF; Davidov ME; Jenkins P; Rofman B; Ginsberg D; Rosenbaum R; Ryan JR; Jain AK; Mroczek WJ
    Arch Intern Med; 1989 Nov; 149(11):2437-41. PubMed ID: 2684073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum uric acid level, longitudinal blood pressure, renal function, and long-term mortality in treated hypertensive patients.
    Dawson J; Jeemon P; Hetherington L; Judd C; Hastie C; Schulz C; Sloan W; Muir S; Jardine A; McInnes G; Morrison D; Dominiczak AF; Padmanabhan S; Walters M
    Hypertension; 2013 Jul; 62(1):105-11. PubMed ID: 23690348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical effectiveness of low-dose chlorthalidone (6.25 mg) + atenolol combination in stage I hypertensive patients: a multicenter, randomized, controlled study.
    Pareek A; Karnik N; Salagre SB; Zawar SD; Joglekar VK; Chandurkar N; Naik GS
    Curr Med Res Opin; 2008 Jun; 24(6):1771-9. PubMed ID: 18479589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chlorthalidone in mild hypertension - dose response relationship.
    Russell JG; Mayhew SR; Humphries IS
    Eur J Clin Pharmacol; 1981; 20(6):407-11. PubMed ID: 7286051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-analysis of dose-response relationships for hydrochlorothiazide, chlorthalidone, and bendroflumethiazide on blood pressure, serum potassium, and urate.
    Peterzan MA; Hardy R; Chaturvedi N; Hughes AD
    Hypertension; 2012 Jun; 59(6):1104-9. PubMed ID: 22547443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemodynamic effects of cadralazine or chlorthalidone in verapamil-treated elderly hypertensives.
    Antonicelli R; Savonitto S; Tomassini PF; Gambini C; Sardina M; Paciaroni E
    Int J Clin Pharmacol Ther; 1994 Apr; 32(4):198-203. PubMed ID: 8032580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative antihypertensive effects of hydrochlorothiazide and chlorthalidone on ambulatory and office blood pressure.
    Ernst ME; Carter BL; Goerdt CJ; Steffensmeier JJ; Phillips BB; Zimmerman MB; Bergus GR
    Hypertension; 2006 Mar; 47(3):352-8. PubMed ID: 16432050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.